CTI Biopharma Corp

Form 483

Seattle, Washington, United StatesFEI 1000135672Issued November 18, 2009

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1000135672.

Observations1

Issue DateNovember 18, 2009

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: CTI Biopharma Corp
Location: Seattle, Washington, United States
FEI Number: 1000135672
Product Type: Drugs
Issue Date: November 18, 2009
Country: United States

Inspection History, 2009 to 2021

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

CTI Biopharma Corp FDA Form 483, Seattle, Washington, November 18, 2009